Validation of 8-isoprostane and prostaglandin E2 measurements in exhaled breath condensate

[1]  P. Montuschi.  Analysis of Exhaled Breath Condensate , 2004 .

[2]  P. Montuschi,et al.  Exhaled leukotrienes and prostaglandins in asthma. , 2002, The Journal of allergy and clinical immunology.

[3]  Paolo Montuschi,et al.  Indirect monitoring of lung inflammation , 2002, Nature Reviews Drug Discovery.

[4]  K. Garey,et al.  Collection and analysis of exhaled breath condensate in humans. , 2001, American journal of respiratory and critical care medicine.

[5]  P. Barnes,et al.  Exhaled markers of pulmonary disease. , 2001, American journal of respiratory and critical care medicine.

[6]  N. Lazzeri,et al.  Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers. , 2000, American journal of respiratory and critical care medicine.

[7]  Massimo Corradi,et al.  Exhaled 8-isoprostane as a new non-invasive biomarker of oxidative stress in cystic fibrosis , 2000, Thorax.

[8]  P. Montuschi,et al.  Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients. , 1999, American journal of respiratory and critical care medicine.

[9]  K. Chung,et al.  Inflammatory mediators of asthma: an update. , 1998, Pharmacological reviews.

[10]  B. Christman,et al.  Exhaled breath condensate isoprostanes are elevated in patients with acute lung injury or ARDS. , 1998, Chest.

[11]  J. Morrow,et al.  Evidence that the E 2 -isoprostane, 15-E 2t -isoprostane (8-iso-prostaglandin E 2 ) is formed in vivo , 1998 .

[12]  A Bast,et al.  Oxidative stress in chronic obstructive pulmonary disease. Oxidative Stress Study Group. , 1997, American journal of respiratory and critical care medicine.

[13]  G. FitzGerald,et al.  Immunological characterization of urinary 8-epi-prostaglandin F2 alpha excretion in man. , 1995, The Journal of pharmacology and experimental therapeutics.

[14]  I. Pavord,et al.  Bronchoprotective role for endogenous prostaglandin E2 , 1995, The Lancet.

[15]  Phillips Yy,et al.  Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986. , 1987, The American review of respiratory disease.

[16]  D. Altman,et al.  STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.

[17]  J. Morrow,et al.  A series of prostaglandin F 2-like compounds are produced in vivo in humans by a non-cyclooxygenase , free radical-catalyzed mechanism ( eicosanoids / oxidative stress / lipid peroxidation / mass spectrometry ) , 2022 .